Neubase Therapeutics Inc. buy elfe
Start price
31.01.15
/
50%
€2,596.8
Target price
01.06.15
€4,800.0
Performance (%)
-64.20%
End price
01.06.15
€929.60
Summary
This prediction ended on 01.06.15 with a price of €929.60. The BUY prediction by elfe for Neubase Therapeutics Inc. performed very badly with a performance of -64.20%. elfe has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Neubase Therapeutics Inc. | - | - | - | - |
| iShares Core DAX® | 3.002% | 3.742% | 24.169% | 65.664% |
| iShares Nasdaq 100 | 2.966% | 1.308% | 9.141% | 111.170% |
| iShares Nikkei 225® | 5.606% | 4.472% | 21.237% | 55.883% |
| iShares S&P 500 | 2.312% | 1.880% | 6.333% | 67.956% |
Comments by elfe for this prediction
In the thread NeuBase Therapeutics Inc. diskutieren
Neue Wege und klare Lösungen, Ohr Pharmaceutical auf dem weg neuartige Therapien zu finden.
Marktplazierung: 172,85 Millionen Euro
Anzahl der Aktien: 25,39 Millionen
Kaufsignal
(Vom Mitglied beendet)